Death, taxes and uncertainty: Economic motivations in end-of-life decision making
George Mellgard(Memorial Sloan Kettering Cancer Center), Jacob M. Appel(Icahn School of Medicine at Mount Sinai)
Cited by 1
Related Papers
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors
|Journal of Cancer Research and Clinical Oncology|2022|23
Hurricanes and healthcare: a case report on the influences of Hurricane Maria and managed Medicare in treating a Puerto Rican resident
|BMC Health Services Research|2019|17
Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors.
|Journal of Clinical Oncology|2020|16
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis
|Discover Oncology|2022|12
Complexity, Not Severity: Reinterpreting the Sliding Scale of Capacity
|Cambridge Quarterly of Healthcare Ethics|2022|12